SYNPLOGEN

Synplogen Co., Ltd. is a synthetic biology startup established in February 2017, originating from Kobe University's Graduate School of Science, Technology and Innovation. Using our proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB, we provide DNA synthesis and DNA library construction services, and as a biofoundry specializing in gene therapy, "Gene Therapy Biofoundry™", we also provide design, development and analysis services for gene therapy products such as viral vectors and mRNA... We provide Gene Therapy Biofoundry™ services related to commercializing research for gene therapy products (Chemistry, Manufacturing and Control: CMC). In addition, through collaborations with domestic and overseas development partner companies capable of GMP-compliant manufacturing, we have established an integrated development and manufacturing value chain that will contribute to early entry into clinical trials and early commercialization of innovative gene therapy products.

Also known as: Synplogen Co., Ltd.

Primary location: Kobe Japan